Rating History for Trillium Therapeutics (TRIL) by Craig-Hallum

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
8/24/2021 Robert Garner Downgrade Hold
(Buy)
N/A
(N/A)
17.59
(19.86)
12.91% Details